Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Company intends to reach Rs 3000 Cr by 2025
A pioneer and global leader in health science and nutraceuticals, Sami-Sabinsa Group has announced the launch of its new manufacturing facility at Pharma SEZ Industrial Area, Hassan, Karnataka.
The first phase of the plant will house a 40,000 square metres world-class Active Nutraceutical Ingredients (ANI) manufacturing unit, with an annual capacity of 300 tons and will be completed by September 2020. The second phase is targetted for 60,000 square metres. The full facility will be functional by 2021. The new facility with a planned investment of Rs. 200 crore is part of the Sami-Sabinsa Group’s growth strategy.
Speaking at a press conference held in Bengaluru, Dr. Muhammed Majeed, Founder & Chairman, Sami-Sabinsa Group said, “World over, consumers are seeking alternatives to better health and looking for food and beverages that supply all their nutritional needs. As the pioneer and among the few Indian companies to have created a global market for patented formulations in the health space, we are committed to a research-oriented, science-based approach towards developing products that make lives healthier and better. The upcoming facility at Hassan, is a reinforcement of this commitment. The new unit when operational will play a pivotal role in boosting our exports further and help us to double our revenues. The first phase, once functional in 2021, will provide employment to around 400 qualified workforce in the fast-growing industrial region of Hassan”.
Exhibiting a total revenue of Rs 1200 crore during the FY18-19, the company intends to reach Rs 3000 crore in the next five years. The company is also exploring to step into Brazil and Russia in the coming times.